Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".

ABSTRACT:

SUBMITTER: Voruz S 

PROVIDER: S-EPMC5830398 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature